New York State Common Retirement Fund’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-33,136
Closed -$2.49M 3572
2022
Q2
$2.49M Sell
33,136
-54
-0.2% -$2.4K ﹤0.01% 1546
2022
Q1
$891K Buy
33,190
+22
+0.1% +$739 ﹤0.01% 2169
2021
Q4
$1.58M Sell
33,168
-11,670
-26% -$522K ﹤0.01% 1893
2021
Q3
$2.98M Sell
44,838
-6,846
-13% -$488K ﹤0.01% 1542
2021
Q2
$4.03M Buy
51,684
+4,408
+9% +$326K ﹤0.01% 1441
2021
Q1
$4.47M Sell
47,276
-8,430
-15% -$1M ﹤0.01% 1335
2020
Q4
$6.79M Buy
55,706
+5,425
+11% +$594K 0.01% 1135
2020
Q3
$4.39M Buy
50,281
+17,245
+52% +$1.2M 0.01% 1216
2020
Q2
$2.13M Buy
33,036
+1,500
+5% +$86.5K ﹤0.01% 1507
2020
Q1
$1.41M Hold
31,536
﹤0.01% 1572
2019
Q4
$1.96M Buy
31,536
+19,260
+157% +$916K ﹤0.01% 1636
2019
Q3
$462K Hold
12,276
﹤0.01% 2376
2019
Q2
$500K Buy
+12,276
New +$438K ﹤0.01% 2377

New York State Common Retirement Fund's TPTX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 33,136 shares — an estimated $2.49M sold.

New York State Common Retirement Fund first reported a position in TPTX in Q2 2019 and held it in 13 quarters. The position peaked at $6.79M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 33,136 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.49M.
  • New York State Common Retirement Fund first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • New York State Common Retirement Fund's Turning Point Therapeutics, Inc. Common Stock position peaked at $6.79M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.